Try our Advanced Search for more refined results
February 02, 2012
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al
Case Number:
2:12-cv-00638
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 06, 2012
Mylan, Shire Battle Again Over Generic Vyvanse
Mylan Inc. and Johnson Matthey Inc. became the latest targets Thursday of drugmaker Shire LLC's ongoing efforts to protect its patents for the attention deficit hyperactivity disorder treatment Vyvanse.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login